Abstract:Objective To study the active components and potetial mechanism of Pogostemon cablin in the treatment of gastric cancer based on network pharmacology and molecular docking.Methods The main active components of Pogostemon cablin were collected through TCMSP platform screening and literature mining. The targets of gastric cancer were screened through GeneCards database. The active components were mapped to the disease targets by R programming language, and the interaction network of gastric cancer targeting proteins was constructed and analyzed by String database, R programming language and Cytoscape software. Gene ontology (GO) function enrichment and Kyoto Encyclopedia of genes and genomes (KEGG) enrichment were conducted on Metascape website. The molecular docking between the active components of Pogostemon cablin and gastric cancer targets was verified by DS software.Results There were 7 active components in Pogostemon cablin, corresponding to 143 targets of gastric cancer. They acted mainly through AKT1, IL-6, EGFR, MMP9, VEGFA, CASP3, MARK1 and other key targets, via pathways in cancer, IL-17 signaling pathway, platinum resistance, NF-κB signaling pathway, transcription disorders in cancer, vascular endothelial growth factor signaling pathway, etc. At least five active components could be successfully docked with the core target AKT1, and the quercetin 7-O-β-D-glucoside could be bound to AKT1 the most stably.Conclusion Pogostemon cablin could inhibit the gastric cancer through multi-compound, multi-target, and multi-pathway.